Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5888

Mammoth Biosciences plans first trial of triglyceride-lowering gene editing therapy

$
0
0
SEVILLE, SPAIN — Mammoth Biosciences, a biotech co-founded by Nobel laureate and CRISPR co-inventor Jennifer Doudna, has revealed the first monkey data from its lead program, a gene editing therapy that may permanently lower triglycerides. ...

Viewing all articles
Browse latest Browse all 5888

Trending Articles